Free Trial

TerrAscend (OTCMKTS:TRSSF) Stock Price Down 6.5% - Here's Why

TerrAscend logo with Medical background

Key Points

  • TerrAscend Corp. experienced a significant drop in stock price, falling by 6.5% to a trading value of $0.80 during mid-day trading.
  • The stock saw a notable increase in trading volume, with 442,276 shares changing hands, which is a 238% rise from its average session volume.
  • TerrAscend is involved in the cannabis industry, cultivating and selling medical and adult use cannabis in Canada and the United States, and operates retail dispensaries under the Apothecarium brand.
  • Five stocks we like better than TerrAscend.

TerrAscend Corp. (OTCMKTS:TRSSF - Get Free Report)'s stock price fell 6.5% during mid-day trading on Friday . The stock traded as low as $0.80 and last traded at $0.80. 442,276 shares changed hands during trading, an increase of 238% from the average session volume of 131,026 shares. The stock had previously closed at $0.86.

TerrAscend Price Performance

The business has a 50-day simple moving average of $0.86 and a 200 day simple moving average of $0.52. The company has a debt-to-equity ratio of 0.55, a current ratio of 0.73 and a quick ratio of 0.40.

About TerrAscend

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in TerrAscend Right Now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.